Evidence map›Paper›PMID 40080279›Full record

ReviewJournal of cancer education : the official journal of the American Association for Cancer Education2025

Brachytherapy as a Cancer Therapy Tool.

Mustafa M Al Balushi, Martin T King

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of cancer education : the official journal of the American Association for Cancer Education, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mustafa M Al BalushiDepartment of Radiation Oncology, Dana Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. m.albalushi-3@cccrc.gov.om.
Martin T KingDepartment of Radiation Oncology, Dana Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brachytherapy (BT) is a core cancer treatment modality that delivers targeted radiotherapy through the placement of radioactive sources inside or near the area to be treated. This provides a very conformal distribution of dose that minimizes radiation exposure to normal organs. This review introduces healthcare professionals (nurses, nurse navigators, public health practitioners, family physicians, and others) to the principles, applications, and future directions of BT. It covers the intent of treatment in oncology, the different types of BT, conditions that are treated with BT and the characteristics of common BT radioactive isotopes. BT's unique characteristics allow physicians to use it in curative and palliative settings for a wide range of malignant and benign indications. Despite its importance, there are still challenges in terms of accessibility and awareness, highlighting the need for comprehensive education and specialized training in this area. In view of the rising incidence of cancer, the demand for qualified brachytherapists is expected to rise accordingly, given its essential role in cancer care. Furthermore, emerging areas in BT such as the implementation of artificial intelligence and 3-dimensional (3D) printing technology hold promise for improving the accuracy and efficiency of this modality.

Indexed as

BrachytherapyNeoplasmsHumansBrachytherapyCancer treatmentInternal radiation therapy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.